Atransferrinemia
(Redirected from Hypotransferrinemia)
Atransferrinemia, not to be confused with hypotransferrinemia, is an autosomal recessive metabolic disorder in which there is an absence of transferrin, a plasma protein that transports iron through the blood.[1][2]
Atransferrinemia is characterized by anemia and hemosiderosis in the heart and liver. The iron damage to the heart can lead to heart failure. The anemia is typically microcytic and hypochromic (the red blood cells are abnormally small and pale). Atransferrinemia was first described in 1961 and is extremely rare, with only ten documented cases worldwide.[3]
Symptoms and signs[edit | edit source]
The presentation of this disorder entails anemia, arthritis, hepatic anomalies, and recurrent infections are clinical signs of the disease.[4] Iron overload occurs mainly in the liver, heart, pancreas, thyroid, and kidney [5]
Genetics[edit | edit source]
In terms of genetics of atransferrinemia researchers have identified mutations in the TF gene as a probable cause of this genetic disorder in affected people.[1]
Transferrin is a serum transport protein that transports iron to the reticuloendothelial system for utilization and erythropoiesis, since there is no transferrin in atransferrinemia, serum free iron cannot reach reticuloendothelial cells and there is microcytic anemia.[6][7][8] Also, this excess iron deposits itself in the heart, liver and joints, and causes damage. Ferritin, the storage form of iron gets secreted more into the bloodstream so as to bind with the excessive free iron and hence serum ferritin levels rise in this condition[medical citation needed]
Diagnosis[edit | edit source]
The diagnosis of atransferrinemia is done via the following means to ascertain if an individual has the condition:[1]
- Blood test(for anemia)
- TF level
- Physical exam
- Genetic test
Types[edit | edit source]
There are two forms of this condition that causes an absence of transferrin in the affected individual:[9]
- Acquired atransferrinemia
- Congenital atransferrinemia
Treatment[edit | edit source]
The treatment of atransferrinemia is apotransferrin. The missing protein without iron. Iron treatment is detrimental as it does not correct the anemia and is a cause of secondary hemochromatosis.[10]
See also[edit | edit source]
References[edit | edit source]
- ↑ 1.0 1.1 1.2 RESERVED, INSERM US14 -- ALL RIGHTS. "Orphanet: Congenital atransferrinemia". www.orpha.net. Retrieved 2017-02-20.
{{cite web}}: CS1 maint: numeric names: authors list (link) - ↑ "OMIM Entry - # 209300 - ATRANSFERRINEMIA". omim.org. Retrieved 19 February 2017.
- ↑ "Atransferrinemia". National Organization for Rare Disorders. Retrieved 20 February 2017.
- ↑ "Atransferrinemia | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 2017-02-20.
- ↑
- ↑
- ↑ Reference, Genetics Home. "TF gene". Genetics Home Reference. Retrieved 2017-02-20.
- ↑ "OMIM Entry - * 190000 - TRANSFERRIN; TF". omim.org. Retrieved 20 February 2017.
- ↑
- ↑
Further reading[edit | edit source]
External links[edit | edit source]
| Classification |
|---|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD
